Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis

New meta‐analyses are presented that provide further evidence supporting the effectiveness of oral prolonged‐release mesalazine compared to other oral mesalazines as induction therapy in patients with moderately active ulcerative colitis.

Saved in:
Bibliographic Details
Published in:JGH open 2023-07, Vol.7 (7), p.516-519
Main Authors: Paridaens, Kristine, Fullarton, John R, Travis, Simon P L
Format: Article
Language:English
Subjects:
aminosalicylates
Brief Report
delayed‐release
effectiveness
Endoscopy
Inflammatory bowel disease
mesalamine
Meta-analysis
Remission (Medicine)
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:New meta‐analyses are presented that provide further evidence supporting the effectiveness of oral prolonged‐release mesalazine compared to other oral mesalazines as induction therapy in patients with moderately active ulcerative colitis.
ISSN:2397-9070
2397-9070
DOI:10.1002/jgh3.12935